Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris. 1997

A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
Cardiology Section, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

Unstable angina occurs when atherosclerotic plaque ruptures. Recent evidence suggests a role for inflammation in this process. Leukocyte-endothelial cell interactions are important in inflammation and are regulated by cell adhesion molecules. This study was designed to examine the vascular expression of cell adhesion molecules and cytokines in patients with unstable angina. Directional coronary atherectomy was performed in patients with unstable and stable angina. Expression of the cell adhesion molecules P-selectin, E-selectin, and intercellular adhesion molecule-1 in the tissue obtained was examined using immunohistochemistry. In addition, expression of the cytokines tumor necrosis factor-alpha and interleukin-1beta, which participate in the regulation of cell adhesion molecule expression, was also examined. Atherectomy specimens had significantly greater P-selectin expression from patients with unstable angina than from patients with stable angina. P-selectin expression was observed primarily on endothelial cells. There were no differences in any of the other factors between patients with unstable and stable angina. In addition, other clinical and angiographic variables were not associated with differential expression of any of the cell adhesion molecules or cytokines. These results indicate a possible role for P-selectin in the process of unstable angina.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
January 1999, The American journal of cardiology,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
September 2000, The Journal of rheumatology,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
October 1999, The American journal of pathology,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
June 1996, Chest,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
February 2005, Coronary artery disease,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
June 1997, Microcirculation (New York, N.Y. : 1994),
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
July 2002, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
April 1996, The British journal of dermatology,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
July 1998, British journal of cancer,
A N Tenaglia, and A J Buda, and R G Wilkins, and M K Barron, and P R Jeffords, and K Vo, and M O Jordan, and B A Kusnick, and D J Lefer
February 1997, Journal of neurology,
Copied contents to your clipboard!